Idorsia Ltd
SIX:IDIA
Idorsia Ltd
Total Liabilities
Idorsia Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Liabilities
CHf1.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Total Liabilities
$509m
|
CAGR 3-Years
5%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Liabilities
$343.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Liabilities
CHf154.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-9%
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Liabilities
CHf33.3m
|
CAGR 3-Years
30%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Total Liabilities
CHf15.4m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
Glance View
Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
See Also
What is Idorsia Ltd's Total Liabilities?
Total Liabilities
1.6B
CHF
Based on the financial report for Dec 31, 2025, Idorsia Ltd's Total Liabilities amounts to 1.6B CHF.
What is Idorsia Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
1%
Over the last year, the Total Liabilities growth was -7%. The average annual Total Liabilities growth rates for Idorsia Ltd have been 1% over the past three years .
